Market Overview

UPDATE: ISI Group Initiates Allscripts Healthcare Solutions with Market Weight, $11 PT on Product Development Overhang

Related MDRX
Market Wrap For March 14: Ukraine Tension Drag Markets Lower
UPDATE: Morgan Stanley Reiterates on Allscripts Healthcare Solutions as Momentum will Continue in 2014
Related MDRX
Benzinga's Top Initiations
Allscripts ePrescribe 17.1 Receives ONC-ACB Certification by Drummond Group

ISI Group initiated its coverage on Allscripts Healthcare Solutions (NASDAQ: MDRX) with a rating of Market Weight and a price target of $11.

ISI Group noted, "Our thesis for MDRX is based on continued issues related to product development efforts and the overhang that this creates on bookings growth, the potential for renewed cross-sell opportunities following the product revamp, and the trade-off between cost synergies and increased R&D spending limiting margin expansion opportunities. However, with the recent sell-off in the stock, we think that the appropriate risk level is assumed in valuation and MDRX continues to have one of the largest installed bases in the market."

Allscripts Healthcare Solutions closed at $10.21 on Wednesday.

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Most Popular

Related Articles (MDRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free